Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Nat Prod Res ; 33(17): 2574-2578, 2019 Sep.
Article de Anglais | MEDLINE | ID: mdl-29620448

RÉSUMÉ

Several Bauhinia species are widely used in Southern South America in the treatment of infections, pain and several diseases including diabetes. Flavonoid compounds based on quercetin and kaempferol glycoside derivatives are believed to be responsible for their therapeutic properties. To investigate this, we have studied two native species from Argentina: B. uruguayensis (BU) and B. forficata subsp. pruinosa (BF). We have analyzed the major polyphenol components in hydro-methanolic extracts of leaves, by high performance liquid chromatography tandem mass spectrometry. Chromatographic analysis yielded five main compounds in BF, corresponding to rutinosides and rhamnosides derivatives of kaempferol and quercetin, which are considered chemotaxonomic markers and responsible for antioxidant activity. The presence of kaempferitrin, an antidiabetic agent, has been confirmed. In extracts of BU, four major compounds were identified as rhamnosides and galloyl derivates from quercetin and kaempferol. One of these compounds, quercitrin-3-rhamnoside may confer anti-inflammatory and analgesic properties to BU extracts.


Sujet(s)
Bauhinia/composition chimique , Flavonoïdes/analyse , Hétérosides/analyse , Analgésiques/isolement et purification , Anti-inflammatoires/isolement et purification , Chromatographie en phase liquide à haute performance , Flavonoïdes/composition chimique , Hétérosides/composition chimique , Hypoglycémiants/isolement et purification , Kaempférols/analyse , Extraits de plantes/composition chimique , Feuilles de plante/composition chimique , Quercétine/analogues et dérivés , Quercétine/analyse , Spectrométrie de masse en tandem
2.
Biosens Bioelectron ; 41: 211-7, 2013 Mar 15.
Article de Anglais | MEDLINE | ID: mdl-22975092

RÉSUMÉ

In this article, we report the first integrated microfluidic immunosensor coupled to a screen-printed carbon electrode (SPCE) applied to determination of clenbuterol (CLB) in bovine hair samples. CLB is a member of the ß(2)-agonist drugs which is used in animal production and is banned in Argentine and the European Union. It represents a potential risk and has to be carefully monitored to avoid the illegal use of high amounts of this compound that could result in human food poisoning. In order to perform the CLB detection, the SPCE was modified by gold nanoparticles (AuNPs) electrodeposition. Quantitative determination of CLB was carried out using a competitive indirect immunoassay, method based on the use of anti-CLB antibodies immobilized on magnetic micro particles. The CLB present in bovine hair samples competes immunologically with alkaline phosphatase (AP) enzyme-labeled CLB conjugate for the anti-CLB specific antibodies. Later, p-aminophenyl phosphate was converted to p-aminophenol by AP, and the electroactive product was quantified on AuNPs/SPCE at +0.1 V. The limit of detection for electrochemical method was 0.008 ng mL(-1) and the intra- and inter-assay coefficients of variation were below 6%. This being a veterinary control tool very useful for rapid, sensitive and selective detection of CLB in an "in vitro" technique.


Sujet(s)
Aliment pour animaux/analyse , Clenbutérol/analyse , Conductimétrie/instrumentation , Contamination des aliments/analyse , Poils/composition chimique , Dosage immunologique/instrumentation , Techniques d'analyse microfluidique/instrumentation , Animaux , Bovins , Galvanoplastie/méthodes , Conception d'appareillage , Analyse de panne d'appareillage , Analyse d'aliment/instrumentation
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE